dockets: FDA-2026-N-10606

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id title docket_type last_modified object_id rin dkabstract category subtype keywords program short_title effective_date organization attrs_raw attr_source
FDA-2026-N-10606 FDA Dermatologic and Ophthalmic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments—New Drug Application (NDA) 219694 for atropine sulfate ophthalmic solution, 0.01% Nonrulemaking 2026-10-14T16:39:30Z 0b000064b9515dd8                     list_pull

Links from other tables